| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | |||||||||||||||||||||||||||
2 | |||||||||||||||||||||||||||
3 | |||||||||||||||||||||||||||
4 | |||||||||||||||||||||||||||
5 | 2024 PRICE LIST | ||||||||||||||||||||||||||
6 | For orders please call +1 954-275-3599, email quotes@wbscientific.com or click here to visit our website at www.wbscientific.com | ||||||||||||||||||||||||||
7 | W&B Part # | Chemical Name | Synonyms | CAS No | Related CAS No | Molecular Formula | Molecular Weight | ||||||||||||||||||||
8 | WBSTD00001 | Ondansetron EP Impurity G | 3-((1H-imidazol-1-yl)methyl)-9-methyl-2,3-dihydro-1H-carbazol-4(9H)-one | 99614-03-6 | 99614-04-7(HCl) | C17H17N3O | 279.34 | ||||||||||||||||||||
9 | WBSTD00002 | Hyoscine Butylbromide EP Impurity D | (1R,2R,4S,5S,7s,9S)-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-9-propyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide | 30269-50-2 | 99603-29-9(Free Base) | C20H28NO4 Br | 346.45 79.90 | ||||||||||||||||||||
10 | WBSTD00003 | Daunorubicin Impurity 49 | 9-acetyl-7,9-bis((4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 105454-45-3 | 99457-12-2(2HCl) | C32H38N2O11 | 626.66 | ||||||||||||||||||||
11 | WBSTD00004 | Biotin EP Impurity G | (3aR,8aS,8bS)-1,3-dibenzyl-2-oxodecahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium bromide | 33719-11-8 | 99297-09-3(free base) | C22H25N2OS Br | 365.51 79.90 | ||||||||||||||||||||
12 | WBSTD00005 | Adenosine 5'-triphosphate | Adenosine 5'-triphosphate | 56-65-5 | 987-65-5(disodium salt);34369-07-8(sodium salt, hydrate) | C10H16N5O13P3 | 507.18 | ||||||||||||||||||||
13 | WBSTD00006 | Drotaverine Impurity 5 | 1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline | 14009-24-6 | 985-12-6(HCl) | C24H31NO4 | 397.52 | ||||||||||||||||||||
14 | WBSTD00007 | Panipenem | (5R,6S)-6-((R)-1-hydroxyethyl)-3-(((S)-1-(1-iminoethyl)pyrrolidin-3-yl)thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | 87726-17-8 | 98167-70-5(Deleted) | C15H21N3O4S | 339.41 | ||||||||||||||||||||
15 | WBSTD00008 | Roxatidine | 2-hydroxy-N-(3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)acetamide | 78273-80-0 | 97900-88-4(HCl salt);110925-92-3(oxalate) | C17H26N2O3 | 306.40 | ||||||||||||||||||||
16 | WBSTD00009 | Docusate sodium Impurity 6 | 4-((2-ethylhexyl)oxy)-4-oxo-2-sulfobutanoic acid | 63294-52-0 | 96954-01-7(2Na salt);115960-17-3(Na salt) | C12H22O7S | $310.36 | ||||||||||||||||||||
17 | WBSTD00010 | Diquafosol Impurity 22 | sodium ((2R,3S,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate | 42155-08-8 | 964-26-1(free) | C9H11N2Na2O8P | 352.15 | ||||||||||||||||||||
18 | WBSTD00011 | Vortioxetine | 1-(2-((2,4-DiMethylphenyl)thio)phenyl)piperazine | 508233-74-7 | 960203-27-4(HBr Salt);1253056-29-9(hydroxypropanoate) | C18H22N2S | 298.45 | ||||||||||||||||||||
19 | WBSTD00012 | heptane-1,7-diamine | heptane-1,7-diamine | 646-19-5 | 95930-98-6(Deleted) | C7H18N2 | 130.24 | ||||||||||||||||||||
20 | WBSTD00013 | Eplerenone EP Impurity F | 3-((4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)propanoic acid | 579484-30-3 | 95716-98-6(Potassium salt) | C24H32O7 | 432.51 | ||||||||||||||||||||
21 | WBSTD00014 | (4,5-dihydro-1H-imidazol-2-yl)methanol | (4,5-dihydro-1H-imidazol-2-yl)methanol | 61764-85-0 | 95185-87-8(hydrochloride) | C4H8N2O | 100.12 | ||||||||||||||||||||
22 | WBSTD00015 | Tafamidis | 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid | 594839-88-0 | 951395-08-7(meglumine) | C14H7Cl2NO3 | 308.11 | ||||||||||||||||||||
23 | WBSTD00016 | 2,4-D-Sodium salt monohydrate | Sodium 2,4-Dichlorophenoxyacetate Monohydrate; 2,4-Dichlorophenoxyacetic Acid Sodium Salt; (2,4-Dichlorophenoxy)acetic acid sodium salt monohydrate | N/A | 94-75-7(free); 2702-72-9(Na salt ) | C8H5Cl2O3 Na H2O | 220.03 22.99 18.02 | ||||||||||||||||||||
24 | WBSTD00017 | Amoxicillin Impurity 28 (Amoxicillin dimer) | (2S,5R,6R)-6-((R)-2-((R)-2-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-2-((2S,4S)-4-carboxy-5,5-dimethylthiazolidin-2-yl)acetamido)-2-(4-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | C32H38N6O10S2 | 730.81 | ||||||||||||||||||||||
25 | WBSTD00018 | Vortioxetine Impurity 71 | 2-bromoaniline | 615-36-1 | 94718-79-3 (HCl salt) | C6H6BrN | 172.03 | ||||||||||||||||||||
26 | WBSTD00019 | Ampicillin Impurity 24;Ampicillin Trimer | Ampicillin EP Impurity Q(M-2); (4S,4'S)-2,2'-((1R,7R,13R)-1-amino-14-(((2S,5R,6R)-2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-6-yl)amino)-2,5,8,11,14-pentaoxo-1,7,13-triphenyl-3,6,9,12-tetraazatetradecane-4,10-diyl)bis(5,5-dimethylthiazolidine-4-carboxylic acid) | 114977-84-3 | 94659-48-0(3Na) | C48H57N9O12S3 | 1048.21 | ||||||||||||||||||||
27 | WBSTD00020 | Ipratropium Bromide Impurity 29 | (1R,3s,5S)-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol | 3423-23-2 | 94217-34-2(HCl) | C10H19NO | 169.26 | ||||||||||||||||||||
28 | WBSTD00021 | 2-(benzo[d][1,3]dioxol-5-ylamino)ethanol | 2-(benzo[d][1,3]dioxol-5-ylamino)ethanol | 81329-90-0 | 94158-14-2(HCl) | C9H11NO3 | 181.19 | ||||||||||||||||||||
29 | WBSTD00022 | Fluvastatin Impurity 13 | (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid | 155229-76-8 | 94061-81-1(sodium salt) | C24H26FNO4 | 411.47 | ||||||||||||||||||||
30 | WBSTD00023 | 2,3-dihydroxypropyl acetate | 2,3-dihydroxypropyl acetate | 106-61-6 | 93713-40-7(Deleted) | C5H10O4 | 134.13 | ||||||||||||||||||||
31 | WBSTD00024 | Olodaterol Impurity 22 | (R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-hydroxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one | 869493-97-0 | 936490-85-6(HCl Salt ) | C20H24N2O5 | 372.42 | ||||||||||||||||||||
32 | WBSTD00025 | Tacalcitol | 1,24-Dihydroxy Vitamin D3; (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R)-5-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol | 57333-96-7 | 93129-94-3(monohydrate) | C27H44O3 | 416.63 | ||||||||||||||||||||
33 | WBSTD00026 | Canagliflozin | (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | 842133-18-0 | 928672-86-0(1/2*H2O); 1809403-05-1(H2O) | C24H25FO5S | 444.52 | ||||||||||||||||||||
34 | WBSTD00027 | Nintedanib | (Z)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate | 656247-17-5 | 928326-83-4(Deleted) | C31H33N5O4 | 539.62 | ||||||||||||||||||||
35 | WBSTD00028 | Vonoprazan Impurity K | 1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | 928325-68-2 | 928325-69-3(fumarate) | C17H15ClFN3O2S | 379.84 | ||||||||||||||||||||
36 | WBSTD00029 | Imatinib Impurity 25 | Urea,N-(aminoiminomethyl) | 141-83-3 | 926-72-7(HCl salt) | C2H6N4O | 102.10 | ||||||||||||||||||||
37 | WBSTD00030 | 2,2,3,3-tetramethylsuccinimidamide | 2,2,3,3-tetramethylsuccinimidamide | 803635-12-3 | 92442-79-0(2HCl) | C8H18N4 | 170.26 | ||||||||||||||||||||
38 | WBSTD00031 | Pilocarpine hydrochloride | (3S,4R)-3-ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one hydrochloride | 54-71-7 | 92-13-7(free base) | C11H16N2O2*HCl | 208.26*36.46 | ||||||||||||||||||||
39 | WBSTD00032 | Nebivolol Impurity 13 | (S)-1-((S)-6-fluorochroman-2-yl)-2-(((R)-2-((S)-6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol | 119365-25-2 | 920299-27-0(HCl) | C22H25F2NO4 | 405.44 | ||||||||||||||||||||
40 | WBSTD00033 | Nebivolol Impurity 19 (RRRR-Nebivolol) | (R,1R,1'R)-2,2'-azanediylbis(1-((R)-6-fluorochroman-2-yl)ethanol) | 119365-29-6 | 920275-25-8(HCl) | C22H25F2NO4 | 405.44 | ||||||||||||||||||||
41 | WBSTD00034 | Nebivolol Impurity 24 | (R,1S,1'S)-2,2'-azanediylbis(1-((R)-6-fluorochroman-2-yl)ethanol) | 119365-30-9 | 920275-23-6(hydrochloride) | C22H25F2NO4 | 405.44 | ||||||||||||||||||||
42 | WBSTD00035 | Naltrexone EP Impurity J | (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one | 16617-07-5 | 918502-32-6; 936213-37-5(Deleted) | C21H25NO4 | 355.43 | ||||||||||||||||||||
43 | WBSTD00036 | Ambrisentan Impurity 10 | 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid | 178306-51-9 | 917247-88-2(Deleted) | C16H16O4 | 272.30 | ||||||||||||||||||||
44 | WBSTD00037 | Levetiracetam Impurity 34 | ethyl (S)-2-aminobutanoate | N/A | 91462-82-7(HCl salt) | C6H13NO2 | 131.18 | ||||||||||||||||||||
45 | WBSTD00038 | Diazolidinyl urea | 1-(1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea | 78491-02-8 | 913083-75-7(Alternate) | C8H14N4O7 | 278.22 | ||||||||||||||||||||
46 | WBSTD00039 | 28-Epihomobra ssinolide | (3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-((2S,3S,4S,5S)-5-ethyl-3,4-dihydroxy-6-methylheptan-2-yl)-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-one | 80483-89-2 | 90762-61-1(Deleted) | C29H50O6 | 494.71 | ||||||||||||||||||||
47 | WBSTD00040 | Apixaban Impurity 244 | 3,8-diazabicyclo[3.2.1]octane | N/A | 90673-35-1(HCl) | C6H12N2 | 112.18 | ||||||||||||||||||||
48 | WBSTD00041 | Teneligliptin | ((2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone | 760937-92-6 | 906093-29-6(HBr);1572583-29-9(hydrobromide, hydrate(2:5:X)) | C22H30N6OS | 426.58 | ||||||||||||||||||||
49 | WBSTD00042 | Azelnidipine Impurity 3 | 1-benzhydrylazetidin-3-ol | 18621-17-5 | 90604-02-7(HCl) | C16H17NO | 239.31 | ||||||||||||||||||||
50 | WBSTD00043 | Vitamin B6 Impurity 85 | 5-hydroxy-4-(hydroxymethyl)-6-methylnicotinaldehyde hydrochloride | 6560-46-9 | 90005-85-9(hydrochloride) | C8H9NO3 HCl | 167.16 36.46 | ||||||||||||||||||||
51 | WBSTD00044 | Levetiracetam Impurity V | 2-aminobutanamide | 53726-14-0 | 89603-48-5(HCl salt) | C4H10N2O | 102.13 | ||||||||||||||||||||
52 | WBSTD00045 | Edoxaban Impurity 122 | 3-bromo-1-methylpiperidin-4-one | 735223-66-2 | 89580-42-7(hydrobroMide) | C6H10BrNO | 192.06 | ||||||||||||||||||||
53 | WBSTD00046 | Diphenidol Hydrochloride Impurity 11 | 1-(4,4-diphenylbut-3-en-1-yl)piperidine | N/A | 89410-63-9(hydrochloride) | C21H25N | 291.44 | ||||||||||||||||||||
54 | WBSTD00047 | (S)-2-aminobutanenitrile | (S)-2-aminobutanenitrile | 631921-68-1 | 887277-58-9(HCl) | C4H8N2 | 84.12 | ||||||||||||||||||||
55 | WBSTD00048 | Atorvastatin EP Impurity F | (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-heptanoic Acid Calcium Salt | 1105067-87-5;1371615-56-3(Na salt) | 887196-24-9 (free base) | C40H47FN3O8·1/2Ca | 736.86 | ||||||||||||||||||||
56 | WBSTD00049 | Beraprost discontinued see RM-B053200 | 4-(2-hydroxy-1-(3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoic acid | 88430-50-6 | 88475-69-8(Na salt) | C24H30O5 | $398.50 | ||||||||||||||||||||
57 | WBSTD00050 | Beraprost Sodium Salt | sodium 4-(2-hydroxy-1-(3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate | 88475-69-8 | 88430-50-6(free base) | C24H29O5*Na | C24H29O5*Na | ||||||||||||||||||||
58 | WBSTD00051 | Vonoprazan Impurity 186 discontinued see RM-V141600 | 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | 881681-00-1 | 881681-01-2(Fumarate) | C17H16FN3O2S | 345.39 | ||||||||||||||||||||
59 | WBSTD00052 | Vonoprazan (discontinued) | 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | 881681-01-2 | 881681-00-1(Fumaric acid); 1260141-27-2(Deleted) | C17H16FN3O2S | 345.39 | ||||||||||||||||||||
60 | WBSTD00053 | Vonoprazan | 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | 881681-01-2 | 881681-00-1(free base);1260141-27-2(delete) | C17H16FN3O2S | 345.39 | ||||||||||||||||||||
61 | WBSTD00054 | Amlodipine mesylate | 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate methanesulfonate | 246852-12-0 | 88150-42-9(free base); 88150-47-4(maleate); 111470-99-6(besylate) | C20H25ClN2O5*CH4O3S | 408.88*96.10 | ||||||||||||||||||||
62 | WBSTD00055 | Amlodipine besylate | 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate benzenesulfonate | 111470-99-6 | 88150-42-9(free base); 88150-47-4(maleate) | C20H25ClN2O5 C6H6O3S | 408.88 158.18 | ||||||||||||||||||||
63 | WBSTD00056 | Cinepazide Impurity D | (E)-2-(4-(3-(3,4,5-trimethoxyphenyl)acryloyl)piperazin-1-yl)acetic acid | 40104-03-8 | 88133-87-3(HCl) | C18H24N2O6 | 364.39 | ||||||||||||||||||||
64 | WBSTD00057 | Doxylamine EP Impurity B | 1-phenyl-1-(pyridin-2-yl)ethanol | 19490-92-7 | 879671-67-7(HCl) | C13H13NO | 199.25 | ||||||||||||||||||||
65 | WBSTD00058 | Vitamin B6 Impurity 88 | 4-(hydroxymethyl)-2,5-dimethylpyridin-3-ol | 4811-03-4 | 875-26-3(HCl) | C8H11NO2 | 153.18 | ||||||||||||||||||||
66 | WBSTD00059 | Aprepitant Impurity 34 | (2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-phenylmorpholine | 171338-33-3 | 874460-46-5(HCl salt) | C20H19F6NO2 | 419.36 | ||||||||||||||||||||
67 | WBSTD00060 | Vitamin B6 Impurity 57 | 1-((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methyl)-4,5-bis(hydroxymethyl)-2-methylpyridin-1-ium-3-olate | 18436-47-0 | 873383-14-3(free) | C16H20N2O5 | 320.34 | ||||||||||||||||||||
68 | WBSTD00061 | hydroxymethanesulfonic acid | hydroxymethanesulfonic acid | 75-92-3 | 870-72-4(sodium salt) | CH4O4S | 112.10 | ||||||||||||||||||||
69 | WBSTD00062 | L-Lactic acid | (S)-2-hydroxypropanoic acid | 79-33-4 | 867-56-1(sodium salt) | C3H6O3 | 90.08 | ||||||||||||||||||||
70 | WBSTD00063 | Alogliptin Impurity 30 | (R)-2,2'-((6-(3-aminopiperidin-1-yl)-2,4-dioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))dibenzonitrile benzoate | NA | 865759-10-0(free base) | C25H24N6O2 C7H6O2 | 440.50 122.12 | ||||||||||||||||||||
71 | WBSTD00064 | tert-Butanol | 2-methylpropan-2-ol | 75-65-0 | 865-47-4(potassium salt) | C4H10O | 74.12 | ||||||||||||||||||||
72 | WBSTD00065 | (1R,3S)-Benazepril HCl | 2-((S)-3-(((R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid hydrochloride | 86541-77-7 | 86541-76-6(free base) | C24H28N2O5 HCl | 424.49 36.46 | ||||||||||||||||||||
73 | WBSTD00066 | Benazepril HCl | 2-((S)-3-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid hydrochloride | 86541-74-4 | 86541-75-5(free base) | C24H28N2O5*HCl | 424.50*36.46 | ||||||||||||||||||||
74 | WBSTD00067 | Drotaverine hydrochloride Impurity 18 | 1-(3,4-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinoline 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetate | 61954-97-0 | 861-27-8(free base) | C24H31NO4*C9H10N4O4 | 397.52*238.20 | ||||||||||||||||||||
75 | WBSTD00068 | Calcium Dobesilate Impurity 26 | 2-hydroxy-3-methoxybenzenesulfonic acid | 4753-08-6 | 859188-04-8(potassium salt) | C7H8O5S | 204.20 | ||||||||||||||||||||
76 | WBSTD00069 | Metamizole sodium EP Impurity C | 1,5-dimethyl-4-(methylamino)-2-phenyl-1H-pyrazol-3(2H)-one | 519-98-2 | 856307-27-2(HCl) | C12H15N3O | 217.27 | ||||||||||||||||||||
77 | WBSTD00070 | Rosuvastatin Impurity 94(Rosuvastatin (6S)-Isomer) | (3R,5S)-5-((S)-8-fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5-dihydroxypentanoic acid | 854898-53-6 | 854898-50-3(1/2Ca) | C22H28FN3O6S | 481.54 | ||||||||||||||||||||
78 | WBSTD00071 | Benzydamine Impurity 3 | 1-benzyl-2-(3-(dimethylamino)propyl)-1,2-dihydro-3H-indazol-3-one | 52413-42-0 | 85284-06-6(HCl) | C19H23N3O | 309.41 | ||||||||||||||||||||
79 | WBSTD00072 | 11652 Dispersed Red | Aluminum, [7-hydroxy-8-[(4-sulfo-1-naphthalenyl)azo]-1,3-naphthal enedisulfonato(3-)]-; aluminum (E)-7-hydroxy-8-((4-sulfonatonaphthalen-1-yl)diazenyl)naphthalene-1,3-disulfonate | 15876-47-8 | 84878-06-8(Deleted) | C20H11AlN2O10S3 | 562.47 | ||||||||||||||||||||
80 | WBSTD00073 | Afatinib Impurity 85 | (E)-4-(dimethylamino)but-2-enoic acid | 149586-32-3 | 848133-35-7(hydrochloride) | C6H11NO2 | 129.16 | ||||||||||||||||||||
81 | WBSTD00074 | Valaciclovir EP Impurity H | (S)-2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl 2-aminopropanoate | 84499-64-9 | 84499-63-8(HCl) | C11H16N6O4 | 296.28 | ||||||||||||||||||||
82 | WBSTD00075 | Sibutramine Impurity 39 | 1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutan-1-amine | N/A | 84484-78-6(HCl) | C15H22ClN | 251.80 | ||||||||||||||||||||
83 | WBSTD00076 | Sibutramine Impurity 38 | 1-(1-(4-chlorophenyl)cyclobutyl)-N,3-dimethylbutan-1-amine | 168835-59-4 | 84467-94-7(hydrochloride) | C16H24ClN | 265.83 | ||||||||||||||||||||
84 | WBSTD00077 | Bedaquiline Fumarate | (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol fumarate | 845533-86-0 | 843663-66-1(free) | C32H31BrN2O2 C4H4O4 | 555.52 116.07 | ||||||||||||||||||||
85 | WBSTD00078 | 2-bromo-2,2-difluoroacetic acid | 2-bromo-2,2-difluoroacetic acid | 354-08-5 | 84349-27-9(sodium salt) | C2HBrF2O2 | 174.93 | ||||||||||||||||||||
86 | WBSTD00079 | 5-Hydroxy Saxagliptin-[13C,D2] TFA Salt | BMS 510849-[13C,D2] TFA Salt; M2 Saxagliptin Hydroxylated Metabolite-[13C,D2]; (1S,3S,5S)-2-((S)-2-amino-2-((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)acetyl-1-13C)-2-azabicyclo[3.1.0]hexane-6,6-d2-3-carbonitrile 2,2,2-trifluoroacetate | N/A | C1713CH23D2N3O3.C2HF3O2 | 448.44 | |||||||||||||||||||||
87 | WBSTD00080 | Nafamostat Impurity 19 | 6-carbamimidoylnaphthalen-2-yl 4-aminobenzoate | 82955-97-3 | 82955-98-4(dimethanesulfonate) | C18H15N3O2 | 305.34 | ||||||||||||||||||||
88 | WBSTD00081 | Calcium Dobesilate Impurity 15 | 4-hydroxybenzenesulfonic acid | 98-67-9 | 825-90-1(sodium salt) | C6H6O4S | 174.17 | ||||||||||||||||||||
89 | WBSTD00082 | Nizatidine EP Impurity J | 2-[(N,N-Dimethylamino)methyl]-4-(hydroxymethyl) thiazole | 78441-69-7 | 82586-70-7(HCl) | C7H12N2OS | 172.25 | ||||||||||||||||||||
90 | WBSTD00083 | Sitagliptin EP Impurity A | (S)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate | 823817-58-9 | 823817-55-6(free base) | C16H15F6N5O. H3PO4 | 407.32 97.99 | ||||||||||||||||||||
91 | WBSTD00084 | 1,3-dihydroxypropan-2-yl dihydrogen phosphate | 1,3-dihydroxypropan-2-yl dihydrogen phosphate | 17181-54-3 | 819-83-0(2sodium salt);13408-09-8(2sodium salt,5hydrate) | C3H9O6P | 172.07 | ||||||||||||||||||||
92 | WBSTD00085 | Warfarin sodium | sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-4-olate | 129-06-6 | 81-81-2(free) | C19H15O4 Na | 307.33 22.99 | ||||||||||||||||||||
93 | WBSTD00086 | Bambuterol EP Impurity C | 3-(2-(tert-butylamino)-1-hydroxyethyl)-5-hydroxyphenyl dimethylcarbamate | 81732-67-4 | 81732-52-7(HCl salt) | C15H24N2O4 | 296.37 | ||||||||||||||||||||
94 | WBSTD00087 | Pravastatin EP Impurity A | (3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]- 1, 2, 6, 7, 8, 8a-hexahydronaphthalen-1-yl]heptanoic acid | 250737-12-3 | 81176-41-2(sodium salt) | C23H35NaO7 | 446.51 | ||||||||||||||||||||
95 | WBSTD00088 | Esmolol HCl | methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)propanoate hydrochloride | 81161-17-3 | 81147-92-4(free base) | C16H26ClNO4 | 331.83 | ||||||||||||||||||||
96 | WBSTD00089 | Neridronic acid | (6-amino-1-hydroxyhexane-1,1-diyl)diphosphonic acid | 79778-41-9 | 80729-79-9(sodium salt) | C6H17NO7P2 | 277.15 | ||||||||||||||||||||
97 | WBSTD00090 | Bupropion Impurity 29 | (1S,2R)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-ol | N/A | 80478-43-9(Hydrochloride) | C13H20ClNO | 241.76 | ||||||||||||||||||||
98 | WBSTD00091 | Folic Acid Impurity 78 | (4S)-4-(4-(3-amino-1-oxo-1,2,5,6,6a,7-hexahydro-8H-imidazo[1,5-f]pteridin-10-ium-8-yl)benzamido)-4-carboxybutanoate | 807328-63-8 | 804563-04-0(chloride) | C20H21N7O6 | $455.43 | ||||||||||||||||||||
99 | WBSTD00092 | Riboflavin-3’-Phosphate | (2S,3S,4R)-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-2,4,5-trihydroxypentan-3-yl dihydrogen phosphate | N/A | 80400-93-7(sodium salt) | C17H21N4O9P | 456.35 | ||||||||||||||||||||
100 | WBSTD00093 | Vitamin B6 Impurity 58 | 1-((5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl)methyl)-4,5-bis(hydroxymethyl)-2-methylpyridin-1-ium-3-olate | 19203-53-3 | 802860-63-5(free base); 19598-93-7(chloride, hydrochloride) | C16H20N2O5 | 320.34 | ||||||||||||||||||||